Optimising excipient selection
Selecting excipients to solubilise compounds is a vital part of the drug development process.
Automating this element of the drug development cycle will help pharmaceutical companies to improve their formulation strategies and in the long-run take new therapeutics to market more efficiently.
Scientists at Recipharm have developed a unique high-throughput screening (HTS) method capable of automating the screening process, saving time, materials and ultimately cost. In this Q&A with CPhI Online, Dr Amjad Alhalaweh a formulation scientist at Recipharm discusses the technique and its benefits over traditional, trial and error- based approaches.
Read the full Q&A here: Automating the process of screening excipients for solubilising drug candidates
Find out more about our high-throughput screening method here.